APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 67 filers reported holding APTOSE BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $48,901 | +11.2% | 76,409 | +0.8% | 0.01% | 0.0% |
| Q4 2022 | $43,980 | +15.7% | 75,829 | +17.7% | 0.01% | +25.0% |
| Q3 2022 | $38,000 | 0.0% | 64,400 | +24.6% | 0.01% | 0.0% |
| Q2 2022 | $38,000 | -45.7% | 51,706 | 0.0% | 0.01% | -27.3% |
| Q1 2022 | $70,000 | -11.4% | 51,706 | -11.4% | 0.01% | -8.3% |
| Q4 2021 | $79,000 | -38.8% | 58,380 | -1.7% | 0.01% | -36.8% |
| Q3 2021 | $129,000 | -64.6% | 59,380 | -45.8% | 0.02% | -63.5% |
| Q2 2021 | $364,000 | -44.4% | 109,567 | -0.0% | 0.05% | -48.0% |
| Q1 2021 | $655,000 | +60.5% | 109,611 | +17.8% | 0.10% | +53.8% |
| Q4 2020 | $408,000 | -19.0% | 93,065 | +10.8% | 0.06% | -39.3% |
| Q3 2020 | $504,000 | -0.4% | 83,984 | +4.7% | 0.11% | -13.0% |
| Q2 2020 | $506,000 | +59.6% | 80,214 | +43.6% | 0.12% | +78.3% |
| Q4 2019 | $317,000 | +173.3% | 55,847 | 0.0% | 0.07% | +155.6% |
| Q3 2019 | $116,000 | -20.5% | 55,847 | 0.0% | 0.03% | -12.9% |
| Q2 2019 | $146,000 | – | 55,847 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 565,000 | $768,000 | 0.80% |
| SANDERS MORRIS HARRIS LLC | 2,342,694 | $3,186,000 | 0.62% |
| Nantahala Capital Management | 7,322,189 | $9,958,000 | 0.44% |
| DRW Securities, LLC | 8,892,437 | $12,094,000 | 0.33% |
| PRECEPT MANAGEMENT LLC | 227,000 | $309,000 | 0.33% |
| Voss Capital, LLC | 550,000 | $748,000 | 0.24% |
| CARLSON CAPITAL L P | 1,564,700 | $2,128,000 | 0.15% |
| Annandale Capital, LLC | 200,000 | $272,000 | 0.11% |
| Sigma Planning Corp | 791,274 | $1,076,000 | 0.03% |
| WealthShield Partners, LLC | 104,920 | $143,000 | 0.02% |